跳到主要內容

Opaleye Management Inc. 的 Form 4 申報

Protara Therapeutics, Inc.(TARA),2024/7/11 申報

申報編號
0001493152-24-027028
申報時間
2024/7/11
交易日
2024/7/9-7/11
申報延遲
2 天
10b5-1 計畫
沒有勾選

這份申報列了 6 筆非衍生性交易。公開市場賣出合計 $17.6 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Opaleye Management Inc.CIK 0001595855持股 10% 以上大股東

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2024/7/9Common Stock, par value $0.001 per shareS賣出處分−5,997$2.21F3−$13,253.372,207,477間接
2024/7/9Common Stock, par value $0.001 per shareS賣出處分−2,500$2.21F3−$5,52580,000間接
2024/7/10Common Stock, par value $0.001 per shareS賣出處分−13,061$2.31F4−$30,170.912,194,416間接
2024/7/10Common Stock, par value $0.001 per shareS賣出處分−5,000$2.31F4−$11,55075,000間接
2024/7/11Common Stock, par value $0.001 per shareS賣出處分−32,993$2.40F5−$79,183.22,161,423間接
2024/7/11Common Stock, par value $0.001 per shareS賣出處分−15,000$2.40F5−$36,00060,000間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F3

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.2128-$2.25 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.

表 I 有 2 筆交易的價格引用這則附註。

F4

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.20-$2.313 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.

表 I 有 2 筆交易的價格引用這則附註。

F5

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.3688-$2.4602 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.

表 I 有 2 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)